Clinical evaluation of B-domain deleted recombinant factor VIII in previously treated patients
- 1 April 2001
- journal article
- Published by Elsevier in Seminars in Hematology
- Vol. 38, 44-51
- https://doi.org/10.1016/s0037-1963(01)90108-8
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- A Multicenter Study of Recombinant Factor VIII (RecombinateTM) in Previously Treated Patients with Hemophilia AThrombosis and Haemostasis, 1997
- The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and ReliabilityThrombosis and Haemostasis, 1995
- Incidence of development of factor VIII and factor IX inhibitors in haemophiliacsThe Lancet, 1992
- Human Recombinant DNA–Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia ANew England Journal of Medicine, 1990
- In vitro and in vivo Characterization of Factor VIII PreparationsVox Sanguinis, 1980
- Characteristics of Various Factor VIII Concentrates used in Treatment of Haemophilia ABritish Journal of Haematology, 1977